Pam Groover serves as a Principal Safety Operations Specialist at Syneos Health, where she leverages her extensive expertise in pharmacovigilance and drug safety to drive critical projects within the Global Safety and Pharmacovigilance department. With a strong focus on preparing requests for information (RFIs), cost...
Pam Groover serves as a Principal Safety Operations Specialist at Syneos Health, where she leverages her extensive expertise in pharmacovigilance and drug safety to drive critical projects within the Global Safety and Pharmacovigilance department. With a strong focus on preparing requests for information (RFIs), cost assessments, and comprehensive proposals for both clinical and post-marketing drug and device projects, Pam plays a pivotal role in ensuring that her team meets the rigorous demands of the industry. Her involvement in bid defense activities not only showcases her strategic acumen but also highlights her ability to communicate complex safety data effectively to stakeholders.
Pam's past experience managing adverse event projects in collaboration with medical officers and regulatory affairs personnel has equipped her with a nuanced understanding of the regulatory landscape. This background enables her to oversee the meticulous processes involved in global regulatory reporting, ensuring compliance and safety across diverse markets. Her proficiency with industry-standard tools such as MedDRA, Argus Safety, and ARISg enhances her capability to analyze and report on safety data accurately.
In addition to her technical skills, Pam is dedicated to mentoring and training the next generation of professionals in the field. Her hands-on training approach fosters a collaborative environment, empowering team members to excel in project coordination and safety operations. With a keen eye for detail and a commitment to excellence, Pam Groover continues to make significant contributions to Syneos Health, driving innovation and safety in drug development and post-marketing surveillance.
